Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « randomized »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
randomization < randomized < randomly  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 43.
[0-20] [0 - 20][0 - 43][20-40]
Ident.Authors (with country if any)Title
000016 (2009) Mao Mao An [République populaire de Chine] ; Zui Zou [République populaire de Chine] ; Hui Shen [République populaire de Chine] ; Jun Dong Zhang [République populaire de Chine] ; Yong Bing Cao [République populaire de Chine] ; Yuan Ying Jiang [République populaire de Chine]The addition of tocilizumab to DMARD therapy for rheumatoid arthritis: a meta-analysis of randomized controlled trials
000026 (2016) Young Ho Lee [Corée du Sud] ; Sang-Cheol Bae [Corée du Sud]Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta‐analysis of randomized controlled trials
000087 (2011) K. Krüger [Allemagne] ; B. Hellmich [Allemagne] ; A. Rubbert-Roth [Allemagne] ; U. Müller-Ladner [Allemagne] ; A. Kielhorn [Allemagne]Ist der Vergleich verschiedener Studien zur Wirksamkeit von Biologika bei Patienten mit rheumatoider Arthritis möglich?
000088 (2011) Emily Beth Devine [États-Unis] ; Rafael Alfonso-Cristancho [États-Unis] ; Sean D. Sullivan [États-Unis]Effectiveness of Biologic Therapies for Rheumatoid Arthritis: An Indirect Comparisons Approach
000105 (2012) M. Gallego-Galisteo ; A. Villa-Rubio ; E. Alegre-Del Rey [Espagne] ; E. Márquez-Fernández ; J. J. Ramos-BáezIndirect comparison of biological treatments in refractory rheumatoid arthritis
000115 (2014) Selda Celik [États-Unis] ; Yusuf Yazici [États-Unis] ; Hasan Yazici [Turquie]Are sample sizes of randomized clinical trials in rheumatoid arthritis too large?
000130 (2007) Gerald Gartlehner [Autriche, États-Unis] ; Richard A. Hansen [États-Unis] ; Beth L. Jonas [États-Unis] ; Patricia Thieda [États-Unis] ; Kathleen N. Lohr [États-Unis]Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence
000161 (2013) I. Kötter [Allemagne] ; J. C. Henes [Allemagne]Etablierte Medikamente
000166 (2013) J. Wollenhaupt [Allemagne] ; K. Albrecht [Allemagne] ; K. Krüger [Allemagne] ; U. Müller-Ladner [Allemagne]The new 2012 German recommendations for treating rheumatoid arthritis
000201 (2014) Kosmas Kretsos [Royaume-Uni] ; Georg Golor [Allemagne] ; Astrid Jullion [Belgique] ; Matthew Hickling [Royaume-Uni] ; Suzanne Mccabe [Belgique] ; Stevan Shaw [Royaume-Uni] ; Joby Jose [Royaume-Uni] ; Ruth Oliver [Royaume-Uni]Safety and pharmacokinetics of olokizumab, an anti‐IL‐6 monoclonal antibody, administered to healthy male volunteers: A randomized phase I study
000206 (2012) K. Krüger [Allemagne] ; J. Sieper [Allemagne]Off-Label-Therapie bei rheumatoider Arthritis und Spondyloarthritiden
000315 (2011) Kjell Tullus [Royaume-Uni]New developments in the treatment of systemic lupus erythematosus
000461 (2011) Alberto Migliore [Italie, Espagne] ; Emanuele Bizzi [Italie] ; Serena Broccoli [Italie] ; Bruno Laganà [Italie]Indirect comparison of etanercept, infliximab, and adalimumab for psoriatic arthritis: mixed treatment comparison using placebo as common comparator
000590 (2013) Benjamin Terrier [France] ; Luc Mouthon [France]Lupus érythémateux systémique
000614 (2013) G. R. Burmester [Allemagne] ; A. Rubbert-Roth [Allemagne] ; A. Cantagrel [France] ; S. Hall [Australie] ; P. Leszczynski [Pologne] ; D. Feldman [Brésil] ; M. J. Rangaraj ; G. Roane ; C. Ludivico [États-Unis] ; E. Mysler [Argentine] ; L. Rowell [Royaume-Uni] ; I. Vranic [Royaume-Uni]SAT0105 Summacta: A Randomized, Double-Blind, Parallel Group Study of the Safety and Efficacy Of Tocilizumab SC Versus Tocilizumab IV, in Combination with Traditional Dmards in Patients With Moderate to Severe Ra
000640 (2013) B. Combe [France] ; M. Dougados [France] ; I. Logeart ; C. Lukas [France] ; X. Mariette [France] ; X. Puechal ; A. Saraux ; T. Schaeverbeke [France]AB0516 An open-label randomized controlled study to evaluate the efficacy of etanercept (ETN) versus rituximab (RTX), in patients with active rheumatoid arthritis previously treated with RTX and TNF blockers
000725 (2013) J. A. Singh [États-Unis] ; G. Wells [Canada] ; R. Christensen [Danemark] ; E. Ghogomu [Canada] ; J. Macdonald [Canada] ; L. Maxwell [Canada] ; S. Tarp [Danemark] ; R. Buchbinder [Australie] ; P. Tugwell [Canada]OP0071 Risk of Cancer, Serious Lung Infections and Death with Biologics: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials (RCTS)
000793 (2011) Sheila L. Arvikar [États-Unis] ; Mark C. Fisher [États-Unis]Inflammatory bowel disease associated arthropathy
000804 (2013) T. Takeuchi [Japon] ; Y. Kaneko [Japon] ; T. Atsumi ; Y. Tanaka ; M. Inoh ; H. Kobayashi [Japon] ; K. Amano ; M. Miyata ; Y. Murakawa ; T. Fujii ; A. Kawakami ; H. Yamanaka ; K. Yamamoto ; N. Miyasaka [Japon] ; T. MimoriOP0040 Adding Tocilizumab or Switching to Tocilizumab Monotherapy in RA Patients with Inadequate Response to Methotrexate: 24-Week Results from a Randomized Controlled Study (Surprise Study)
000908 (2013) S. Celik [États-Unis] ; Y. Yazici [États-Unis]SAT0480 How many patients do we really need to enroll in randomized clinical trials of biologic agents for the treatment of rheumatoid arthritis? An analysis of published trials
000967 (2013) V. Bruzzese [Italie] ; R. Lorenzetti [Italie] ; A. Zullo [Italie] ; C. Hassan [Italie] ; S. M. Campo [Italie]OP0070 Anti-TNF Therapy and Tuberculosis Risk in Rheumatic Diseases, Psoriasis, and IBD: A Pooled-Data Analysis of Randomized Controlled Trials

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "randomized" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "randomized" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    randomized
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021